Results 11 to 20 of about 9,656,866 (288)

Degenerative joint disease induced by repeated intra-articular injections of monosodium urate crystals in rats as investigated by translational imaging

Scientific Reports, 2022
The objective of this work was to assess the consequences of repeated intra-articular injection of monosodium urate (MSU) crystals with inflammasome priming by lipopolysaccharide (LPS) in order to simulate recurrent bouts of gout in rats.
Nathalie Accart, Janet Dawson, Michael Obrecht, Christian Lambert, Manuela Flueckiger, Julie Kreider, Shinji Hatakeyama, Peter J. Richards, Nicolau Beckmann   +8 more
doaj   +1 more source

2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

Annals of the Rheumatic Diseases, 2022
Objectives A European League Against Rheumatism taskforce was convened to review the literature and develop recommendations on lifestyle behaviours for rheumatic and musculoskeletal diseases (RMDs). Methods Six lifestyle exposures (exercise, diet, weight,
J. Gwinnutt, M. Wieczorek, A. Bălănescu, H. Bischoff-Ferrari, A. Boonen, G. Cavalli, Savia de Souza, A. de Thurah, T. Dorner, R. Moe, P. Putrik, J. Rodríguez-Carrio, L. Silva-Fernández, T. Stamm, K. Walker-Bone, Joep Welling, M. Zlatković-Švenda, F. Guillemin, S. Verstappen   +18 more
semanticscholar   +1 more source

Challenges documenting racial disparities in Merkel cell carcinoma

Cancer Biology & Therapy, 2022
Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer that predominantly impacts White patients. Overall incidence and the proportion of minority patients with MCC are both rising.
Mackenzie R. Martin, Noreen Mohsin, Serena Vilasi, Danielle Reed, Isaac Brownell   +4 more
doaj   +1 more source

Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study

RMD Open, 2023
Objective Gout is associated with lifestyle, body mass index (BMI) and comorbidities, including dyslipidaemia. We studied how in actively treated patients, anthropometric measures and lipid levels changed over 2 years and whether they predicted gout ...
Tore K Kvien, Joseph Sexton, Till Uhlig, Espen A Haavardsholm, Hilde Berner Hammer, Lars Fridtjof Karoliussen   +5 more
doaj   +1 more source

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

Annals of the Rheumatic Diseases, 2022
Objective To develop recommendations for cardiovascular risk (CVR) management in gout, vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD), Sjögren’s syndrome (SS), systemic lupus erythematosus (SLE) and ...
G. Drosos, D. Vedder, E. Houben, L. Boekel, F. Atzeni, S. Badreh, D. Boumpas, N. Brodin, I. Bruce, M. González-Gay, S. Jacobsen, G. Kerekes, F. Marchiori, C. Mukhtyar, M. Ramos-Casals, N. Sattar, K. Schreiber, S. Sciascia, E. Svenungsson, Z. Szekanecz, A. Tausche, A. Tyndall, V. van Halm, A. Voskuyl, G. Macfarlane, M. Ward, M. Nurmohamed, Maria G. Tektonidou   +27 more
semanticscholar   +1 more source

2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases

Annals of the Rheumatic Diseases, 2023
Objectives Fatigue is prevalent in people with inflammatory rheumatic and musculoskeletal diseases (I-RMDs) and recognised as one of the most challenging symptoms to manage.
E. Dures, B. Farisoğulları, E. Santos, A. Moltó, C. Feldthusen, Claire Harris, C. Elling-Audersch, Deirdre Connolly, E. Elefante, F. Estévez-López, I. Bini, J. Primdahl, Kirsten Hoeper, Marie Urban, M. A. van de Laar, M. Redondo, Peter Böhm, R. Amarnani, Rhys J Hayward, R. Geenen, Simona Rednic, Susanne Pettersson, T. Thomsen, Till Uhlig, Valentin Ritschl, P. Machado   +25 more
semanticscholar   +1 more source

Willingness, perceived facilitators and barriers to use remote care among healthcare professionals – a cross-sectional study

BMC Health Services Research, 2023
Background Remote care has the potential of improving access to timely care for people with inflammatory joint diseases (IJD), but there is limited knowledge on how this approach is regarded by healthcare professionals (HCP).
Emil Eirik Kvernberg Thomassen, Inger Jorid Berg, Eirik Klami Kristianslund, Anne Therese Tveter, Nina Østerås   +4 more
doaj   +1 more source

Effect of a mHealth exercise intervention compared with supervised exercise therapy in osteoarthritis management: protocol of the DigiOA trial

BMJ Open, 2022
Introduction Soaring prevalence of hip and knee osteoarthritis (OA) inflicts high costs on the healthcare system. A further rise in the OA incidence is expected, generating increased demand of care potentially challenging accessibility and threatening to
Nina Østerås, Anne Therese Tveter, Lars Martinsen, Tuva Moseng   +3 more
doaj   +1 more source

Post-Acute COVID-19 Joint Pain and New Onset of Rheumatic Musculoskeletal Diseases: A Systematic Review

Diagnostics, 2023
As the number of reports of post-acute COVID-19 musculoskeletal manifestations is rapidly rising, it is important to summarize the current available literature in order to shed light on this new and not fully understood phenomenon.
J. Ciaffi, E. Vanni, L. Mancarella, V. Brusi, L. Lisi, F. Pignatti, S. Naldi, E. Assirelli, Simona Neri, M. Reta, C. Faldini, F. Ursini   +11 more
semanticscholar   +1 more source

Cell‐Based Therapies for Degenerative Musculoskeletal Diseases

Advancement of science, 2023
Degenerative musculoskeletal diseases (DMDs), including osteoporosis, osteoarthritis, degenerative disc disease, and sarcopenia, present major challenges in the aging population.
Pengbin Yin, Yuheng Jiang, Xuan Fang, Daofeng Wang, Yi Li, Ming Chen, Hao Deng, P. Tang, Licheng Zhang   +8 more
semanticscholar   +1 more source